patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
dabrafenib mesylate ODT
Marketedupdated 2mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 2 investigational indications.
all catalysts(40)
approval · 40
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that